166 related articles for article (PubMed ID: 16175603)
1. CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice.
Moreno C; Gustot T; Nicaise C; Quertinmont E; Nagy N; Parmentier M; Le Moine O; Devière J; Louis H
Hepatology; 2005 Oct; 42(4):854-62. PubMed ID: 16175603
[TBL] [Abstract][Full Text] [Related]
2. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver.
Ajuebor MN; Hogaboam CM; Le T; Proudfoot AE; Swain MG
Eur J Immunol; 2004 Oct; 34(10):2907-18. PubMed ID: 15368307
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor CCR5 deficiency exacerbates cerulein-induced acute pancreatitis in mice.
Moreno C; Nicaise C; Gustot T; Quertinmont E; Nagy N; Parmentier M; Louis H; Devière J
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G1089-99. PubMed ID: 16891300
[TBL] [Abstract][Full Text] [Related]
4. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
[TBL] [Abstract][Full Text] [Related]
5. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice.
Repeke CE; Ferreira SB; Claudino M; Silveira EM; de Assis GF; Avila-Campos MJ; Silva JS; Garlet GP
Bone; 2010 Apr; 46(4):1122-30. PubMed ID: 20053385
[TBL] [Abstract][Full Text] [Related]
6. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes.
Losana G; Bovolenta C; Rigamonti L; Borghi I; Altare F; Jouanguy E; Forni G; Casanova JL; Sherry B; Mengozzi M; Trinchieri G; Poli G; Gerosa F; Novelli F
J Leukoc Biol; 2002 Oct; 72(4):735-42. PubMed ID: 12377943
[TBL] [Abstract][Full Text] [Related]
8. CCR5 deficiency drives enhanced natural killer cell trafficking to and activation within the liver in murine T cell-mediated hepatitis.
Ajuebor MN; Wondimu Z; Hogaboam CM; Le T; Proudfoot AE; Swain MG
Am J Pathol; 2007 Jun; 170(6):1975-88. PubMed ID: 17525265
[TBL] [Abstract][Full Text] [Related]
9. Essential roles of the CC chemokine ligand 3-CC chemokine receptor 5 axis in bleomycin-induced pulmonary fibrosis through regulation of macrophage and fibrocyte infiltration.
Ishida Y; Kimura A; Kondo T; Hayashi T; Ueno M; Takakura N; Matsushima K; Mukaida N
Am J Pathol; 2007 Mar; 170(3):843-54. PubMed ID: 17322370
[TBL] [Abstract][Full Text] [Related]
10. An abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5.
Sato K; Kawasaki H; Morimoto C; Yamashima N; Matsuyama T
J Immunol; 2002 Jun; 168(12):6263-72. PubMed ID: 12055240
[TBL] [Abstract][Full Text] [Related]
11. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis.
Marino AP; da Silva A; dos Santos P; Pinto LM; Gazzinelli RT; Teixeira MM; Lannes-Vieira J
Circulation; 2004 Sep; 110(11):1443-9. PubMed ID: 15337689
[TBL] [Abstract][Full Text] [Related]
12. CCR5 deficiency aggravates crescentic glomerulonephritis in mice.
Turner JE; Paust HJ; Steinmetz OM; Peters A; Meyer-Schwesinger C; Heymann F; Helmchen U; Fehr S; Horuk R; Wenzel U; Kurts C; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2008 Nov; 181(9):6546-56. PubMed ID: 18941245
[TBL] [Abstract][Full Text] [Related]
13. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
[TBL] [Abstract][Full Text] [Related]
14. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.
Murai M; Yoneyama H; Harada A; Yi Z; Vestergaard C; Guo B; Suzuki K; Asakura H; Matsushima K
J Clin Invest; 1999 Jul; 104(1):49-57. PubMed ID: 10393698
[TBL] [Abstract][Full Text] [Related]
15. I-TAC/CXCL11 is a natural antagonist for CCR5.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
[TBL] [Abstract][Full Text] [Related]
16. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
[TBL] [Abstract][Full Text] [Related]
17. Reduced GRK2 level in T cells potentiates chemotaxis and signaling in response to CCL4.
Vroon A; Heijnen CJ; Lombardi MS; Cobelens PM; Mayor F; Caron MG; Kavelaars A
J Leukoc Biol; 2004 May; 75(5):901-9. PubMed ID: 14761932
[TBL] [Abstract][Full Text] [Related]
18. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
Uekusa Y; Yu WG; Mukai T; Gao P; Yamaguchi N; Murai M; Matsushima K; Obika S; Imanishi T; Higashibata Y; Nomura S; Kitamura Y; Fujiwara H; Hamaoka T
Cancer Res; 2002 Jul; 62(13):3751-8. PubMed ID: 12097285
[TBL] [Abstract][Full Text] [Related]
19. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
[TBL] [Abstract][Full Text] [Related]
20. Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.
Cripps JG; Celaj S; Burdick M; Strieter RM; Gorham JD
Lab Invest; 2012 Oct; 92(10):1461-71. PubMed ID: 22906987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]